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Modified MDRD equations outperform
the original equations in Chinese
patients with chronic kidney disease
Original article Ma Y-C et al. (2006) Modified glomerular

filtration rate estimating equation for Chinese patients with
chronic kidney disease. J Am Soc Nephrol 17: 2937–2944

compared with that of the original MDRD equations. See Supplementary Information online
for the full equations.
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OUTCOME MEASURES

The bias, precision and accuracy of the modified
equations were assessed.

BACKGROUND

RESULTS

There is evidence that the MDRD (Modification
of Diet in Renal Disease) equations underestimate glomerular filtration rate (GFR) in
Chinese patients with mild renal insufficiency,
and overestimate GFR in those with severe
renal failure.

Of the 684 patients included in the study (mean
age 49.98 years; 48.5% female), a random
sample of 454 provided the data for modification of the equations. The remaining 230
were used to validate the modified equations.
The four modified MDRD equations showed
significantly higher 15% accuracy than the
two original equations (46.9–50.4% vs 32.6%
for the full MDRD equation and 30.0% for the
abbreviated equation; P <0.05 in all cases).
The modified equations had slightly better
precision (narrower limits of agreement)
than the original equations, ranging from
53.2 to 57.5 ml/min/1.73 m2 (compared with
57.6 ml/min/1.73 m2 for the full MDRD equation
and 60.7 ml/min/1.73 m2 for the abbreviated
equation). Bias of the modified equations was
much lower than that of the original equations
(543–686 vs 2,134–2,175). When the modified
equations were analyzed in each stage of CKD
separately, they had significantly greater 15%
accuracy than the original equations in stages 1
and 2 (P <0.05 for all). In stage 1 CKD, fewer
patients were misclassified as CKD stage 2 by
the new equations than by the original equations (45.2–54.8% vs 71.4–73.8%). In stage
2 CKD, fewer patients were misclassified by
the new equations as stage 3 (30.0–31.7% vs
60.0–68.3%). A final four modified equations
were generated using the entire dataset (see
Supplementary Information online).

OBJECTIVE

To modify the full and abbreviated MDRD
equations in order to improve their predictive
power in Chinese patients with chronic kidney
disease (CKD).
DESIGN AND INTERVENTION

Between June 2004 and September 2005, this
study enrolled adults with CKD at 9 university
hospitals in China. Exclusion criteria included
edema, heart failure and need for renal replacement therapy. The reference GFR value was
determined at each center from the plasma
clearance of 99mTc-DTPA. Plasma creatinine
levels were analyzed centrally; a random selection of plasma samples was also analyzed in
the Cleveland Clinic Laboratory to allow calibration of the values to the MDRD equations.
Using data from a randomly selected subset
of patients, the investigators employed linear
regression to produce modified versions of
the full and abbreviated MDRD equations that
incorporated a factor accounting for Chinese
race. A further two equations were constructed
by refitting the MDRD equations to the same
subset of patients using raw plasma creatinine
values (i.e. without calibration to the MDRD
laboratory). The predictive performance of the
new equations in the remaining patients was
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CONCLUSION

The modified MDRD equations provide better
estimates of GFR in Chinese patients with CKD
than do the original equations.
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CKD is a major public health problem worldwide,
with adverse outcomes including loss of kidney
function, sometimes leading to kidney failure,
and cardiovascular disease. Unfortunately, CKD
is underdiagnosed and undertreated.
Early detection of CKD can be achieved using
markers of kidney damage or more-sensitive
measures of kidney function, such as estimated
GFR. Several formulae, including the MDRD
equation, have been developed to estimate GFR
based on serum creatinine concentration, age,
sex, and body size. Many organizations recommend using these equations to detect, evaluate
and manage CKD.1
In general, the MDRD equation demonstrates
minimal bias and reasonable precision and
accuracy in white patients with CKD and mean
GFR <60 ml/min/1.73 m2. More than 90% of estimates fall within 30% of the measured value.2 The
picture is less clear in predominantly non-CKD
populations (such as kidney donors or patients
with diabetes and high GFR), and in nonwhite
populations. The relationships between the variables used in GFR estimation equations and the
non-GFR determinants of serum creatinine level
(e.g. creatinine generation, secretion and extrarenal
elimination) can vary according to health status
and lifestyle factors (e.g. diet).3 This variation
might lead to increased errors when estimating
GFR in certain ethnic groups that differ from the
population in whom the equations were originally
developed (i.e. whites and African Americans in
the US).4 Consistent with this notion, MDRD
estimates correlate poorly with measured GFR in
Chinese patients with CKD.5
The study by Ma et al. examined the performance of the MDRD equation in Chinese patients
with various stages of CKD, and compared it with
that of modified equations developed specifically for the study population. The modified
equations were generated by adding a term for
Chinese race to the MDRD equation, or by refitting the MDRD equation to the study population using the same variables as were originally
used. The overall performance of the modified
equations was superior to that of the original
equations, with significant improvements in bias,
precision, and accuracy.
The MDRD equation performed poorly
in CKD stages 1 and 2, with about 60–70%
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misclassification. It is important to note that
almost half of the subjects with CKD stages 1
or 2 were still misclassified by the modified
equations. Further, in CKD stages 3–5, there
were no significant differences in performance
between the original and modified equations.
Unfortunately, the investigators did not report
the performance of the Cockcroft–Gault equation, nor did they test the addition of variables
to the MDRD equation that were not included
in the original equation, but could potentially
improve its performance in Chinese patients.
Moreover, the study was limited to patients with
CKD, thus restricting its relevance to those
with high GFR, and to non-CKD populations
at high risk for this condition (e.g. patients with
hypertension or diabetes). Nevertheless, this
important study highlights the challenges of
searching for more accurate estimates of kidney
function in Asian populations.
The practicing clinician should know that
although the modified GFR equations seem to
have some advantage over the original MDRD
equations in Chinese patients, both the original
and modified equations would generate high
numbers of false-positives and false-negatives in
non-CKD populations, and in individuals with
CKD stages 1–2. Confirmation of the estimate
with measurement of 24-h creatinine clearance
will still be required in these situations.
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A modified form of
the MDRD equation
devised specifically
for Chinese patients
might be preferable to
the original equation
for estimation of
GFR in relevant
Asian populations
if its superiority
is confirmed in
subsequent studies
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